CoChat

Randomized discontinuation trials: Utility and efficiency

Kopec, Jacek A., Abrahamowicz, Michal, Esdaile, John M. · 1993 · Journal of Clinical Epidemiology

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

The randomized discontinuation trial (RDT) is a two-phase trial. In phase I all patients are openly treated with the medication being evaluated. In phase II, those who have responded are randomly assigned to continue the same treatment or switch to placebo. Usually, non-compliers and "adverse reactors" identified in phase I are excluded from phase II. To investigate the value of this design, we reviewed the advantages and limitations of discontinuation studies, and compared the RDT design to the classic randomized clinical trial design in terms of clinical utility and efficiency (sample size). A computer model was used to study the efficiency of the two designs under a broad range of assumptions. The RDT design is particularly useful in studying the effect of long-term, non-curative therapies, especially when the clinically important effect is relatively small, and the use of placebo should be minimized for ethical or feasibility reasons. However, its use is limited if the objective of an investigation is to estimate the magnitude of absolute treatment effects and toxic effects in the source population, or to evaluate a potentially curative treatment. Our results indicate that selecting responders prior to randomization has a very strong effect on the relative efficiency of the trial. Further improvement may be achieved by excluding non-compliers and adverse reactors. Under the assumptions tested in our model, the sample size required in phase II of an RDT was only 20-50% of…

Overview

Integrity signals

Registry

Crossref · 10.1016/0895-4356(93)90163-u

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 62 references

Research works printed but not linked: 1

  1. Snider, 1984, Sixmonth isoniazid-rifampin therapy for pulmonary tuberculosis, Am Rev Respir Dis, 129, 573

Cited by

See all 139

Metadata

Authors
Kopec, J. A., Abrahamowicz, M., & Esdaile, J. M.
Affiliations
Montreal General Hospital (CA)
Venue
Journal of Clinical Epidemiology
Publisher
Elsevier BV
Published
1993-09
Volume
46
Issue
9
Pages
959-971
ISSN
0895-4356 (ISSN-L)
OpenAlex
W2073680312
Cited by
134
References
60
Citations by year
2026: 1 · 2025: 3 · 2023: 2 · 2022: 2 · 2020: 6 · 2019: 2 · 2018: 7 · 2017: 5 · 2016: 4 · 2015: 3 · 2014: 8 · 2013: 4 · 2012: 5
FWCI
2.02
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Clinical Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
  • DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (AI 07306, T32AI007306)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60AR036308, AR-36308, AR-07530, T32AR007530)
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
  • Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
Keywords
relative efficiency, sample size, non-compliance, computer simulation, treatment effect estimation
MeSH terms
Computer Simulation, Humans, Models, Theoretical, Placebos, Research Design, Sampling Studies, Randomized Controlled Trials as Topic, Treatment Refusal, Efficiency, Organizational, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized discontinuation trials: Utility and efficiency. https://app.cochat.ai/papers/10.1016/0895-4356(93)90163-u
The paper
Kopec, J. A., Abrahamowicz, M., & Esdaile, J. M. (1993). Randomized discontinuation trials: Utility and efficiency. Journal of Clinical Epidemiology. https://doi.org/10.1016/0895-4356(93)90163-u

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.